Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses
US10836770B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2017 |
| Grant date | Nov 17, 2020 |
| Priority date | — |
| Expiry date | Oct 2, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFNa, by acting on Tyk-2 to cause signal transduction inhibition. The compounds of formula I are useful for the treatment of inflammatory or autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.